|
|
||||||||
Department of Pathophysiology, Center of Internal Medicine, University School of Medicine, 45122 Essen, Germany
| |
ABSTRACT |
|---|
|
|
|---|
The present study characterizes the hemodynamic and neurohumoral responses to moderate treadmill exercise in conscious dogs with pacing-induced heart failure. Seven dogs were instrumented with a left ventricular micromanometer, ultrasonic crystals for the measurement of systolic wall thickening, left atrial and aortic catheters for the injection of colored microspheres and reference withdrawal, respectively, and ventricular pacing leads with a subcutaneous pacemaker. Dogs were run on a treadmill at a speed of 5 km/h. After control studies, heart failure was induced by rapid left ventricular pacing at 250 beats/min for (mean ± SD) 23 ± 6 days. In the control state, cardiac output was increased from 4.5 ± 1.5 to 7.9 ± 1.4 l/min (P < 0.05 vs. rest). With heart failure, cardiac output was decreased to 2.5 ± 0.5 l/min at rest (P < 0.05 vs. control state) and was only 3.0 ± 0.3 l/min during exercise (P < 0.05 vs. control state; not significant vs. rest). Myocardial and, more so, skeletal muscle blood flows at rest were reduced in heart failure; their increases with exercise were attenuated. An increase in renal blood flow during exercise in the control state was no longer seen in heart failure. Increases in plasma catecholamines and lactate during exercise were more pronounced in heart failure. In conclusion, in heart failure, the increase in cardiac output during exercise was largely attenuated. Increased catecholamine levels may have contributed to splanchnic vasoconstriction and preferential distribution of cardiac output into the working skeletal muscle.
cardiac output; catecholamines; lactate
| |
INTRODUCTION |
|---|
|
|
|---|
EXERCISE INTOLERANCE is a salient feature of congestive
heart failure; the severity of heart failure in patients is classified with respect to exercise intolerance, using the criteria developed by
the New York Heart Association (3). Exercise intolerance in heart
failure may be based on both an inadequate increase in cardiac output
and its distribution into the working skeletal muscle as well as
inadequate function and metabolism of skeletal muscle per se (4, 6, 13,
16). Both inadequate perfusion and metabolism of skeletal muscle, in
turn, may induce an increase in plasma catecholamine levels (7) and
thus contribute to myocardial
-adrenoceptor desensitization,
arrhythmias, and increased vasomotor tone in other vascular territories
(8, 37, 39). In fact, the metaboreflex from skeletal muscle not
adequately perfused and metabolically incompetent skeletal muscle may
be a predominant source of increased plasma catecholamines (6), rather
than arterial and cardiac mechanoreflexes (40). The present study used
the established model of pacing-induced heart failure in conscious dogs
(5, 10, 11, 14, 17, 20, 22-24, 31, 35). Dogs were subjected to an
identical moderate treadmill exercise protocol both in the control
state and in heart failure. Cardiac output and its distribution into
the working skeletal muscle, including the diaphragm, as well as into
the kidney (as a splanchnic reference organ), together with plasma
lactate [as an indicator of skeletal muscle anaerobic metabolism
(34)] and catecholamines, were measured. To our best knowledge,
this is the first study to report such comprehensive analysis of
cardiac output distribution, plasma lactate, and catecholamine levels both at rest and during exercise in conscious dogs with pacing-induced heart failure.
| |
METHODS |
|---|
|
|
|---|
The experimental protocols employed in this study were approved by the bioethical committee of the district of Düsseldorf, Germany, and they conform with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.
Instrumentation. The experiments were performed in a total of seven adult mongrel dogs (23-36 kg) of either sex. Before instrumentation, all dogs were accustomed to human handling and trained to run on a treadmill.
Before surgical instrumentation, the dogs were premedicated with 3.0 mg/kg propofol and 0.02 mg/kg fentanyl intravenously. After tracheal intubation, anesthesia was maintained with 10-20 mg · kg
1 · h
1
of propofol and 0.01-0.02
mg · kg
1 · h
1
of fentanyl intravenously. The anesthesia was supplemented by ventilation with isoflurane (0.2-0.4%) in a 30% oxygen-70%
nitrous oxide mixture, using a respirator (Spiromat 656; Dräger
Werke, Lübeck, Germany). During instrumentation, body temperature
was measured with an esophageal probe and kept constant between 37 and
38°C with a heating pad.
The chest was opened in the fifth intercostal space under sterile
conditions. The pericardium was opened, and a micromanometer (model
P-3.5S; Koenigsberg Instruments, Pasadena, CA) was placed in the left
ventricle through the apex together with a fluid-filled silicone
catheter used to calibrate the micromanometer in situ. A polyethylene
catheter was implanted into the left atrium for microsphere injection,
and a Teflon catheter (2.0 mm ID) was implanted into the thoracic
descending aorta for the arterial reference withdrawal. Piezoelectric
crystals were implanted into the left ventricular (LV)
free wall for measurement of regional wall thickness (Sonomicrometer
120; Triton Technologies, San Diego, CA). Pacing leads (model 5071;
Medtronic, Düsseldorf, Germany) were sutured to the LV free wall.
All wires and catheters were exteriorized between the scapulae. The
chest was closed in layers and evacuated. The dogs were placed on an
antibiotic regimen (penicillin, streptomycin) for 6 days
postoperatively. After instrumentation, the dogs were allowed to
recover for 7-10 days before the control experiments. The
positions of all catheters and crystals were confirmed at autopsy.
Induction of heart failure. After completion of the control studies, a pacemaker (Legend II 8424 and 8426, type VVI; Medtronic) was implanted under local anesthesia (2% lidocaine) in a subcutaneous pouch. Heart failure was induced by rapid LV pacing, as originally reported by Coleman et al. (5). The pacing rate was set to 250 beats/min, and minimal voltage and pulse duration for capture were determined, using a programming unit (model 9710; Medtronic). The presence of heart failure was determined from both clinical signs, such as ascites, pulmonary edema, and cachexia, and hemodynamic parameters, such as the increase in LV end-diastolic pressure (LVEDP) and the decreases in LV maximal pressure (LVPmax), maximum rate of LV pressure rise (LV dP/dtmax), and systolic wall thickening. The mean time (± SD) to induce heart failure was 23 ± 6 days, ranging from 15 to 30 days.
Protocols. Seven to ten days after surgery, when the dogs had fully recovered from surgery, control measurements were performed. Measurements were taken with the dog standing on the treadmill and during exercise. Measurements included the assessment of systemic hemodynamics and regional dimensions, microsphere injection for the assessment of cardiac output and regional blood flow, and arterial blood withdrawal for the analysis of plasma catecholamines and lactate. The dogs were run at a speed of 5 km/h for 10 min. Measurements were performed in a hemodynamic steady state, i.e., between 5 and 10 min into the run.
The studies were repeated at an identical exercise level in heart failure. After completion of the study, the dogs were euthanized with a lethal dose of KCl (
10 ml, 1 M).
Measurement of cardiac output and regional blood flow. Cardiac output and regional blood flow were determined with a technique developed in our laboratory (15) using colored microspheres (Dye Trak; Triton Technologies). For each experiment, 8 × 106 to 12 × 106 microspheres suspended in saline solution (containing 0.02% Tween 80) were injected into the left atrium. The number of microspheres was adjusted with respect to the specific absorbance of the respective dye. Simultaneous arterial reference samples were withdrawn from the descending aorta at a constant rate of 5.3 ml/min with a Harvard withdrawal pump (model 901A; Harvard Apparatus, South Natick, MA), starting 30 s before the microsphere injection and continuing for 150 s.
After euthanasia of the dogs, tissue samples were taken from the left (18 samples/animal, i.e., 9 each/transmural layer; weight 0.40 ± 0.10 g) and right ventricles (6 samples/animal; weight 0.57 ± 0.27 g), musculus triceps (8-10 samples/animal; weight 0.74 ± 0.16 g), musculus biceps femoris (8-10 samples/animal; weight 0.70 ± 0.12 g), diaphragm (7 samples/animal; weight 0.48 ± 0.18 g), and the renal medulla (4-6 samples/animal; weight 0.34 ± 0.17 g) and cortex (4-5 samples/animal; weight 0.68 ± 0.31 g). The regional myocardial blood flow in the subendocardium, midmyocardium, and subepicardium of the left ventricle was separately determined. After extraction of the dye from the microspheres, the color spectra of each tissue sample and arterial reference withdrawal sample were measured with a spectrophotometer (model 8452A; Hewlett-Packard, Palo Alto, CA). The absorbance was determined as specific absorbance for each color. Separation of overlapping spectra was performed with a matrix inversion technique. Cardiac output was determined from the measurement of an aliquot of the injected microspheres and the arterial reference withdrawal rate, using the equation cardiac output = reference withdrawal rate × total absorbance of injected microspheres / absorbance in the arterial reference withdrawal sample. The regional blood flow per sample, corrected for wet weight, was calculated according to the equation regional tissue blood flow = reference withdrawal rate × absorbance of sample / absorbance in the arterial reference withdrawal sample. The blood flow values of the respective tissue samples were averaged for each animal.Measurement of catecholamines.
For catecholamine analysis, the blood samples were centrifuged
immediately after withdrawal, and the plasma was frozen in liquid
nitrogen and stored at
70°C. After thawing, 1 ng/ml
3,4-dihydroxybenzylamine was added as an internal
standard. The samples were deproteinized (trichloroacetic acid, 0.3 M
final concentration), and the catecholamines were adsorbed to purified
alumina (1) at pH 8.6 [2.5 M
tris(hydroxymethyl)aminomethane · HCl buffer
containing 10 mM mercaptoethanol]. The alumina-bound catecholamines
were washed three times with 0.8 M acetate buffer, pH 7.5, and once
with water. Then the catecholamines were dissolved in 200 ml 1.0 N
acetic acid. An aliquot of this solution was used for high-performance
liquid chromatography. Separation was achieved on a 3.9 × 150 mm
column (Nova-Pak-C18; Millipore, Eschborn, Germany), the mobile phase
consisting of 1.0 N acetic acid, 22 mM 1-octanesulfonic acid sodium
salt monohydrate, 0.2 mM
EDTA-Na2, with a flow of 1.3 ml/min (pump: Waters M510, Millipore; pulse dampener: LP-21, Scientific
Systems, State College, PA). A glassy carbon electrode set to 650 mV
against Ag-AgCl was used for electrochemical detection (model 400 EC
Detector; EG & G Princeton Applied Research, Princeton, NJ).
Measurement of lactate. Lactate was determined from KF-EDTA-stabilized blood samples, using the lactate dehydrogenase reaction combined with transamination of the formed pyruvate for quantitative NADH formation (18). NADH was measured photometrically.
Data analysis and statistics. LVP, LV rate of pressure rise (LV dP/dt), and regional wall thickness were simultaneously recorded on an eight-channel recorder (model RS800; Gould, Cleveland, OH) and a personal computer. Hemodynamic data were digitized at a rate of 200 Hz and directly stored on hard disk with the use of Cordat II software (28). Systemic hemodynamic and regional wall function data of 15 sequential beats were averaged. End diastole was defined as the time point at which LV dP/dt started its rapid upstroke after crossing the zero line. Regional end systole was defined as the point of maximal wall excursion within 20 ms before peak negative dP/dt. The measured parameters were heart rate, LVPmax and LVEDP, LV dP/dtmax, end-diastolic wall thickness, and systolic wall thickening, presented as the percent change from the end-diastolic thickness. End-diastolic wall thickness was normalized to 10 mm under control conditions (19).
Statistical analysis was performed with Sigma Stat software (Jandel Scientific, San Rafael, CA). Data were analyzed by two-way analysis of variance for repeated measures. When a significant overall effect was detected, single mean values were compared by paired t-tests and subsequent Bonferroni's adjustment. Data are reported as mean values ± SD and are considered statistically significant at P < 0.05.| |
RESULTS |
|---|
|
|
|---|
Baseline hemodynamics. After 3-4 wk of rapid ventricular pacing, dogs developed heart failure, characterized by clinical signs, such as ascites, pulmonary edema, and cachexia (body weight decreased from 25.6 ± 3.4 to 22.4 ± 2.3 kg), and hemodynamic parameters, such as an increase in LVEDP and decreases in LVPmax, dP/dtmax, and systolic wall thickening.
Hemodynamic responses to exercise. In the control state, during moderate exercise, there were significant increases in heart rate, LVPmax, dP/dtmax, and cardiac output (Fig. 1; Table 1). In heart failure, starting from reduced levels at rest, there were still significant increases in LVPmax and dP/dtmax. Heart rate was not different at rest and increased to a similar extent as during control exercise. LVEDP at rest was significantly elevated and increased further during exercise. Cardiac output at rest was markedly reduced in heart failure, and there was no significant increase during exercise (Table 1). In contrast to the control state, all dogs in heart failure had obvious signs of discomfort during exercise.
|
|
Myocardial, skeletal muscle, and renal blood flow. In the control state, blood flow to the myocardium, the working skeletal muscle, including the diaphragm, and the kidney increased during exercise (Table 2). The increase in blood flow to the biceps femoris was most pronounced, whereas the increase in renal blood flow was only modest. In heart failure, blood flow at rest was reduced in all organs studied, particularly in the skeletal muscle. Also, the increases in myocardial and skeletal muscle blood flow during exercise were blunted. In heart failure, renal blood flow was no longer increased.
|
Plasma catecholamines and lactate. In the control state, plasma catecholamines and lactate were increased slightly during exercise (Table 3). In heart failure, plasma catecholamines were increased at rest and increased more markedly during exercise. Also, lactate increased markedly during exercise in heart failure.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study utilized an established experimental model of heart failure, i.e., chronic rapid ventricular pacing in conscious dogs (5, 10, 14, 17, 20, 22-24, 31, 35). This model mimics not only the clinical signs (ascites, pulmonary edema, cachexia) seen in patients with heart failure but also the associated hemodynamic and neurohumoral alterations (increases in LV end-diastolic pressure and plasma catecholamines, decreases in LV maximal pressure, dP/dtmax, and cardiac output).
The exact mechanisms underlying the development of heart failure with chronic rapid ventricular pacing are currently unclear (27) but may be related to abnormalities of intracellular calcium kinetics (20) and myocyte loss (11). To that extent, it is currently unclear whether pacing-induced heart failure shares the same pathophysiology as heart failure in humans. Important for the present study, however, is that exercise intolerance, which is a salient feature of heart failure in humans, is also evident in the pacing-induced heart failure model. The fairly mild severity of heart failure in the present study was similar to that previously reported by others, as judged by the impairment in baseline hemodynamics (2, 5, 11, 14, 20, 22-24, 31, 35) as well as by the increase in resting plasma catecholamines (2, 9, 21). The reduction in cardiac output at rest by an average of 44% in the present study was even more severe than in several prior studies (9, 14, 35), comparable only with that reported by Moe et al. (17).
From a comparison of the baseline data in the control state of the present study with those previously reported (9, 24), it appears from the catecholamine levels that dogs were under some adrenergic activation already at rest, possibly in anticipation of the run. This adrenergic activation was also associated with somewhat higher skeletal muscle blood flow levels compared with the study of Shen et al. (26). In contrast, the intensity of exercise in the present study was fairly mild, as reflected by the only modest increases in plasma catecholamines and lactate as well as the hemodynamic responses under control conditions. More significant increases in plasma catecholamines and lactate were seen only during such mild exercise after the development of heart failure. Such mild exercise intensity was chosen so that dogs could perform an identical exercise protocol in the control state and in heart failure.
Flow measurements in the present study were based on the microspheres technique. We did not attempt to address a potential loss of microspheres over time in the present study. However, from previous studies using the model of pacing-induced heart failure in dogs and swine, no loss of microspheres was reported (25, 29, 30). Also, we did not perform morphological studies. However, prior studies using this model have not reported an increase either in LV muscle mass or in capillary density and cross-sectional area (25, 29).
In heart failure, blood flow to the myocardium at rest was somewhat
less reduced (LV
30% on average; right ventricular
20% on average) than cardiac output (
44% on average). Also, blood flow to the renal cortex was better maintained than cardiac output (
28% on average). In contrast, blood flow to the skeletal
muscle at rest, including the diaphragm, was much more markedly reduced (triceps
62%; biceps femoris
62%; diaphragm
68%). During exercise, the decrease in cardiac output by 62%
on average was even more pronounced compared with rest (
44%),
and the same was true for LV myocardial blood flow (
44% vs.
30% at rest). In contrast, the decreases in skeletal muscle
blood flow during exercise were much less pronounced than those in
cardiac output (triceps
25%; biceps femoris
45%;
diaphragm
33%). Apparently, in heart failure there is a
preferential distribution of cardiac output into the working skeletal
muscle during exercise, as also evidenced by the concomitant albeit not
significant decrease in renal blood flow seen in the present study. No
increase in renal blood flow during exercise in the control state and a
marked decrease in renal blood flow in exercising dogs with heart
failure caused by tricuspid avulsion and pulmonary stenosis were
previously reported (8). However, that particular study
differed from the present one with respect to the heart failure model
(tricuspid avulsion and pulmonary stenosis vs. pacing), exercise
severity (heart rate of 281 ± 25 vs. 166 ± 19 beats/min), and method of flow measurement (Doppler flow probe vs.
microspheres). Despite these differences, both studies indicate a
reversal of the renal blood flow response to exercise with heart
failure. Even with preferential perfusion (relative to cardiac output)
of the working skeletal muscle, there was a significant increase in
plasma lactate, supporting the notion that the skeletal muscle in heart
failure is characterized not only by reduced perfusion (in absolute
terms) but also by primary metabolic abnormalities (13, 16). However,
we did not determine the exact source of increased plasma lactate
(e.g., liver vs. skeletal muscle).
The coronary circulation in this heart failure model is under defective endothelial control (33). Reduced myocardial blood flow at rest and, in addition, in adenosine- or atrial pacing-recruitable coronary reserve has been reported previously in conscious dogs (25) and pigs (29) with pacing-induced heart failure. The impairment in coronary reserve in dogs was selective to the subendocardium (25). In the present study, however, a preferential impairment of subendocardial blood flow was not observed either at rest or during exercise, although extravascular compression, as reflected by LV end-diastolic pressure, was increased. Obviously, at this mild exercise level, an adequate coronary vasomotor response to increased cardiac work was still possible, indicating no enhanced vulnerability of the failing myocardium to ischemia.
Unfortunately, arterial pressure was not measured in the present study, since the arterial line was used for the reference withdrawal during the microsphere measurement of blood flow. Therefore, resistance values cannot be calculated and pressure-dependent changes in blood flow cannot be distinguished from active vasomotion. In particular, the attenuated increases in flow to myocardium and skeletal muscle during exercise and, even more so, the lack of flow increase to the kidney may, in part, be caused by an attenuated increase in arterial pressure, as has been reported in patients with heart failure during exercise (36).
A limitation of the present study is the lack of mechanistic information on the causal relation among hemodynamics, blood flow distribution, plasma catecholamines, and lactate. However, this is the first study to provide integrative information on these parameters during exercise in the model of pacing-induced heart failure. Inadequate nutritive perfusion of skeletal muscle during exercise also has been reported in patients with heart failure (32, 36, 38) and has been related to impaired endothelial function (12). Also, increased lactate production during exercise has been reported in patients with heart failure (32, 36). With respect to the symptom of exercise intolerance and the observed phenotype of hemodynamic, blood flow, plasma catecholamine, and lactate responses to treadmill exercise, the pacing-induced heart failure model in conscious dogs may therefore be useful to analyze the mechanisms of exercise intolerance in future studies.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by interne Forschungsförderung Essen (IFORES) Grant 107-401-0 of the Medical Faculty of the University of Essen.
| |
FOOTNOTES |
|---|
Address for reprint requests: G. Heusch, FESC, FACC, Dept. of Pathophysiology, Center of Internal Medicine, Univ. School of Medicine, Essen, Hufelandstr. 55, 45122 Essen, Germany.
Received 2 June 1997; accepted in final form 1 August 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Anton, A. H.,
and
D. F. Sayre.
A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.
J. Pharmacol. Exp. Ther.
138:
360-374,
1966.
2.
Brändle, M.,
K. P. Patel,
W. Wang,
and
I. H. Zucker.
Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs.
J. Appl. Physiol.
81:
1855-1862,
1996
3.
Braunwald, E.
Clinical manifestations of heart failure.
In: Heart Disease. A Textbook of Cardiovascular Medicine, edited by E. Braunwald. Philadelphia, PA: W. B. Saunders, 1988, p. 471-484.
4.
Coats, A. J. S.
The "muscle hypothesis" of chronic heart failure.
J. Mol. Cell. Cardiol.
28:
2255-2262,
1996[Medline].
5.
Coleman, H. N., III,
R. R. Taylor,
P. E. Pool,
G. H. Whipple,
J. W. Covell,
J. Ross, Jr.,
and
E. Braunwald.
Congestive heart failure following chronic tachycardia.
Am. Heart J.
81:
790-798,
1971[Medline].
6.
Delehanty, J. M.,
and
C. Liang.
Metabolic control of the circulation: implications for congestive heart failure.
Prog. Cardiovasc. Dis.
38:
51-66,
1995[Medline].
7.
Hasking, G. J.,
M. D. Esler,
G. L. Jennings,
E. Dewar,
and
G. Lambert.
Norepinephrine spillover to plasma during steady-state supine bicycle exercise.
Circulation
78:
516-521,
1988
8.
Higgins, C. B.,
S. F. Vatner,
D. Franklin,
and
E. Braunwald.
Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs.
Circ. Res.
31:
186-194,
1972
9.
Holmer, S. R.,
A. J. G. Riegger,
W. F. Notheis,
E. P. Kromer,
and
K. Kochsiek.
Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
Basic Res. Cardiol.
82:
101-108,
1987[Medline].
10.
Hoskins, D. E.,
D. P. Ignasiak,
L. J. Saganek,
K. P. Gallagher,
and
J. T. Peterson.
Myocardial infarct size is smaller in dogs with pacing-induced heart failure.
Cardiovasc. Res.
32:
238-247,
1996
11.
Kajstura, J.,
X. Zhang,
Y. Liu,
E. Szoke,
W. Cheng,
G. Olivetti,
T. H. Hintze,
and
P. Anversa.
The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy.
Circulation
92:
2306-2317,
1995
12.
Katz, S. D.,
H. Krum,
T. Khan,
and
M. Knecht.
Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide.
J. Am. Coll. Cardiol.
28:
585-590,
1996[Abstract].
13.
Kemp, G. J.,
C. H. Thompson,
J. R. Stratton,
F. Brunotte,
M. Conway,
S. Adamopoulos,
L. Arnolda,
G. K. Radda,
and
B. Rajagopalan.
Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis.
Heart
76:
35-41,
1996.
14.
Komamura, K.,
R. P. Shannon,
T. Ihara,
Y. T. Shen,
I. Mirsky,
S. P. Bishop,
and
S. F. Vatner.
Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure.
Am. J. Physiol.
265 (Heart Circ. Physiol 34):
H1119-H1131,
1993
15.
Kowallik, P.,
R. Schulz,
B. D. Guth,
A. Schade,
W. Paffhausen,
R. Gross,
and
G. Heusch.
Measurement of regional myocardial blood flow with multiple colored microspheres.
Circulation
83:
974-982,
1991
16.
Massie, B.,
M. Conway,
R. Yonge,
S. Frostick,
J. Ledingham,
P. Sleight,
G. Radda,
and
B. Rajagopalan.
Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.
Circulation
76:
1009-1019,
1987
17.
Moe, G. W.,
C. Angus,
R. J. Howard,
T. G. Parker,
and
P. W. Armstrong.
Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure.
Cardiovasc. Res.
26:
362-366,
1992
18.
Noll, F.
L-Lactat: Bestimmung mit LDH, GPT und NAD.
In: Methoden der enzymatischen Analyse, edited by H. U. Bergmeyer. Weinheim, Germany: Verlag Chemie, 1970, p. 1433-1437.
19.
Osakada, G.,
O. M. Hess,
K. P. Gallagher,
W. S. Kemper,
and
J. Ross, Jr.
End-systolic dimension-wall thickness relations during myocardial ischemia in conscious dogs. A new approach for defining regional function.
Am. J. Cardiol.
51:
1750-1758,
1983[Medline].
20.
Perreault, C. L.,
R. P. Shannon,
K. Komamura,
S. F. Vatner,
and
J. P. Morgan.
Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure.
J. Clin. Invest.
89:
932-938,
1992.
21.
Pierpont, M. E. M.,
J. E. Foker,
and
G. L. Pierpont.
Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia.
Basic Res. Cardiol.
88:
362-370,
1993[Medline].
22.
Prabhu, S. D.,
and
G. L. Freeman.
Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs.
Circulation
91:
176-185,
1995
23.
Prabhu, S. D.,
and
G. L. Freeman.
Postextrasystolic mechanical restitution in closed-chest dogs. Effect of heart failure.
Circulation
92:
2652-2659,
1995
24.
Riegger, A. J. G.,
and
G. Liebau.
The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog.
Clin. Sci. (Lond.)
62:
465-469,
1982[Medline].
25.
Shannon, R. P.,
K. Komamura,
Y. T. Shen,
S. P. Bishop,
and
S. F. Vatner.
Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H801-H809,
1993
26.
Shen, W.,
M. Lundborg,
J. Wang,
J. M. Stewart,
X. Xu,
M. Ochoa,
and
T. H. Hintze.
Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs.
J. Appl. Physiol.
77:
165-172,
1994
27.
Shinbane, J. S.,
M. A. Wood,
D. N. Jensen,
K. A. Ellenbogen,
A. P. Fitzpatrick,
and
M. M. Scheinman.
Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies.
J. Am. Coll. Cardiol.
29:
709-715,
1997[Abstract].
28.
Skyschally, A.,
R. Schulz,
and
G. Heusch.
Cordat II: a new program for data acquisition and on-line calculation of hemodynamic and regional myocardial dimension parameters.
Comput. Biol. Med.
23:
359-367,
1993[Medline].
29.
Spinale, F. G.,
R. Tanaka,
F. A. Crawford,
and
M. R. Zile.
Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy.
Circulation
85:
717-729,
1992
30.
Spinale, F. G.,
M. Tomita,
J. L. Zellner,
J. C. Cook,
F. A. Crawford,
and
M. R. Zile.
Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia.
Am. J. Physiol.
261 (Heart Circ. Physiol. 30):
H308-H318,
1991
31.
Su, J. B.,
F. Barbe,
M. Laplace,
B. Crozatier,
and
L. Hittinger.
Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
Cardiovasc. Res.
30:
848-856,
1995[Medline].
32.
Sullivan, M. J.,
J. D. Knight,
M. B. Higginbotham,
and
F. R. Cobb.
Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure.
Circulation
80:
769-781,
1989
33.
Wang, J.,
N. Seyedi,
X. B. Xu,
M. S. Wolin,
and
T. H. Hintze.
Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure.
Am. J. Physiol.
266 (Heart Circ. Physiol. 35):
H670-H680,
1994
34.
Weber, K. T.,
and
J. S. Janicki.
Lactate production during maximal and submaximal exercise in patients with chronic heart failure.
J. Am. Coll. Cardiol.
6:
717-724,
1985[Abstract].
35.
Wilson, J. R.,
P. Douglas,
W. F. Hickey,
V. Lanoce,
N. Ferraro,
A. Muhammad,
and
N. Reichek.
Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects.
Circulation
75:
857-867,
1987
36.
Wilson, J. R.,
J. L. Martin,
D. Schwartz,
and
N. Ferraro.
Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.
Circulation
69:
1079-1087,
1984
37.
Yamabe, H.,
K. Itoh,
Y. Yasaka,
T. Takata,
and
M. Yokoyama.
The role of cardiac output response in blood flow distribution during exercise in patients with chronic heart failure.
Eur. Heart J.
16:
951-960,
1995
38.
Zelis, R.,
J. Longhurst,
R. J. Capone,
and
D. T. Mason.
A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure.
Circulation
50:
137-143,
1974
39.
Zelis, R.,
D. T. Mason,
and
E. Braunwald.
Partition of blood flow to the cutaneous and muscular beds of the forearm at rest and during leg excercise in normal subjects and in patients with heart failure.
Circ. Res.
24:
799-806,
1969
40.
Zucker, I. H.,
W. Wang,
M. Brändle,
H. D. Schultz,
and
K. P. Patel.
Neural regulation of sympathetic nerve activity in heart failure.
Prog. Cardiovasc. Dis.
37:
397-414,
1995[Medline].
This article has been cited by other articles:
![]() |
D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aker, S. Belosjorow, I. Konietzka, A. Duschin, C. Martin, G. Heusch, and R. Schulz Serum but not myocardial TNF-{alpha} concentration is increased in pacing-induced heart failure in rabbits Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R463 - R469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl Control of Coronary Blood Flow during Exercise Experimental Biology and Medicine, April 1, 2002; 227(4): 238 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, K. Maehara, K. Tamagawa, Y. Oikawa, T. Niitsuma, S.-I. Saitoh, and Y. Maruyama Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H80 - H86. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |